• Oxyrane announces further progress of development stage projects & sale of Belgian operations

    Friday May 29th 2020

  • VIB single-cell software supported by a Chan Zuckerberg Initiative grant

    Thursday May 28th 2020

  • Mithra signs license and supply agreement with Mayne Pharma for commercialization of Estelle in Australia

    Thursday May 28th 2020

  • Seventure Partners joins ViroVet in series B funding

    Thursday May 28th 2020

  • argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis

    Tuesday May 26th 2020

  • Biotalys awarded €1.6 million VLAIO research grant

    Tuesday May 26th 2020

  • Mithra launches a research programme on Estetrol's effect in Covid-19 treatment

    Monday May 25th 2020

  • Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib

    Thursday May 21st 2020

  • Your news here?

  • Mithra and Searchlight Pharma announce filing of new drug submission for Estelle® in Canada

    Wednesday May 20th 2020

  • ProDigest and CosmosID announce a winner for the ‘Gut Microbiome Therapeutic Innovation’ challenge

    Tuesday May 19th 2020

  • Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

    Monday May 18th 2020


Strategic Partners